In a study on AD patients with diabetes mellitus, no significant differences were detected in the rate of cognitive decline between insulin users and non-users, patients with diet-controlled diabetes or those taking other antidiabetic drugs, including biguanides, SU, glinides or TZD [408]. The gene discussed is INS; the disease is Alzheimer disease.